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A number of diﬀerent approaches have been utilized in
recent years for the treatment of Parkinson’s disease with
varying eﬀects on associated communication disorders. In
particular, the drug treatments based on levodopa therapy
and, more recently, deep brain stimulation of the sub-
thalamic nucleus (STN-DBS) have yielded variable eﬀects
on the speech disorders exhibited by the majority of
persons with Parkinson’s disease. With respect to STN-DBS,
although reports indicate significant improvement in the
symptomatology in Parkinson’s disease associated with limb
function, the majority of reports suggest that the procedure
has either minimal or, in most cases, negative eﬀects on
speech abilities of the aﬀected individuals. By far the most
eﬀective speech therapy technique applied to dysarthria in
Parkinson’s disease reported to date is the Lee Silverman
Voice Treatment (LSVT) program. In addition to speech
impairment, in recent years there has also been increasing
awareness that Parkinson’s disease is also associated with
the occurrence of language disorders, especially in its later
stages. This special issue contains 13 papers of which 10 are
related to issues associated with speech impairment and 3
further papers explore aspects of language impairment in
Parkinson’s disease.
The first paper entitled “Perceived changes in commu-
nication as an eﬀect of STN surgery in Parkinson’s disease:
a qualitative interview study” by E. Ahlberg et al. explored
the perspective of four individuals with Parkinson’s disease
on the way their speech and communication changed as
a result of STN-DBS. Overall the study confirmed earlier
findings of negative eﬀects on speech production; however,
irrespective of this, the patients in general were positive as
to the outcome of their surgery. The paper by F. Karlsson
et al. “Deep brain stimulation of caudal zone incerta and
subthalamic nucleus in patients with Parkinson’s disease: eﬀects
on diadochokinetic rate,” investigated the outcome of STN-
DBS and stimulation of the caudal zone incerta (cZi-DBS)
on articulation rate and quality of plosive consonants in
two articulatory diadochokinetic tasks. Whereas patients
receiving STN-DBS increased in articulation rate with no
eﬀect on production quality, patients receiving cZi-DBS
decreased in articulation rate and further showed reduction
in production quality suggesting that cZi-DBS is more
detrimental for extended articulatory movements than STN-
DBS.
The third paper, “Deep brain stimulation of caudal zone
incerta and subthalamic nucleus in patients with Parkinson’s
disease: eﬀects on voice intensity” by S. Lundgren et al.
compares the eﬀects of cZi-DBS and STN-DBS on voice
intensity of patients with Parkinson’s disease. Overall the
results indicated that the two diﬀerent surgical procedures
may have diﬀerential eﬀects on voice intensity. The fourth
paper by C. Dromey and S. Bjarnason, “A preliminary
report on disordered speech with deep brain stimulation in
individuals with Parkinson’s disease,” attempted to determine
which laryngeal and articulatory acoustic features changed in
patients that reported negative speech outcomes subsequent
to STN-DBS. Acoustic measures of articulation and phona-
tion as well as verbal fluency scores showed mixed results
with STN-DBS.
The fifth paper in this special issue, “Eﬀects of LSVT
on lexical tone in speakers with Parkinson’s disease” by T. L.
Whitehill et al. represents one of the very few studies to have
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investigated the eﬀect of LSVT on lexical tone. The study
involved 12 Cantonese speakers with idiopathic Parkinson’s
disease who underwent standard LSVT treatment. Although
the results showed significant improvement in loudness
and intonation after treatment, no significant changes
were reported in lexical tone. The sixth paper included
in the special issue, “Acoustic analysis of PD speech” by
K. Chenausky et al. investigated speech changes as a result of
STN-DBS settings chosen to maximize motor performance.
Importantly, clinically motivated settings evaluated by the
researchers showed a greater capacity to impair, rather
than improve, speech. Lingual kinematics during consonant
production in both dysarthric and nondysarthric speakers
with Parkinson’s disease were investigated in the seventh
paper, “Lingual kinematics in dysarthric and nondysarthric
speakers with Parkinson’s disease” by M. N. Wong et al.
The findings indicated that dysarthric and nondysarthric
speakers with Parkinson’s disease had deviant articulatory
movement during consonant production that results in
longer duration of consonant production. Importantly, these
findings are contrary to contemporary theories that suggest
articulatory imprecision in dysarthric speakers with Parkin-
son’s disease is an outcome of reduced range of articulatory
movement.
The eighth paper in the current issue, “Assessment of
prosodic communicative eﬃciency in Parkinson’s disease as
judged by professional listeners” by H. Martens et al. investi-
gated the impact of Parkinson’s disease on communicative
eﬃciency conveyed through prosody. Although no signifi-
cant diﬀerences were found for emotional prosody, patients
with a moderate or severe dysarthria performed significantly
worse on imitation of Focus than on reading of Focus.
The ninth paper included in the special issue, “Perception
of speech by individuals with Parkinson’s disease: a review”
by L. C. Kwan and T. L. Whitehill, explored the possibility
of the presence of a deficit in the perception of speech
in individuals with Parkinson’s disease. Based on a review
of the literature, it was concluded that Parkinson’s disease
specifically impairs patients’ perception of verbal emotions.
The aim of the tenth paper, “A cognitive-perceptual approach
to conceptualizing speech intelligibility deficits and remediation
practice in hypokinetic dysarthria” by K. L. Landsford et al.
was to introduce a novel framework for medical practitioners
in order to conceptualize and justify potential targets for
speech remediation in patients with Parkinson’s disease. The
most commonly targeted deficits, including speaking rate
and vocal loudness, were supported by this approach.
The eleventh paper, “High-level language production in
Parkinson’s disease: a review” by L. J. P. Altmann and M.
S. Troche, reviewed the literature on language production
in Parkinson’s disease and provided detailed discussion of
the language production processes that are impaired in this
condition. It was concluded that Parkinson’s disease aﬀects
all stages of language production, including conceptualiza-
tion, functional and positional processing. Two semantic
priming tasks designed to isolate automatic and controlled
semantic activation were utilized in the twelfth paper, “The
influence of dopamine on automatic and controlled semantic
activation in Parkinson’s disease” by W. L. Arnott et al. to
investigate the impact of dopamine depletion on semantic
processing in Parkinson’s disease. Overall, the results demon-
strated that dopamine depletion can cause disturbances in
both automatic and controlled semantic activation. The
final paper in this special issue, “Sentence comprehension
and its association with executive functions in patients with
Parkinson’s disease” by K. S. F. Colman et al. aimed to provide
insight into the interaction between linguistic representation
and processing and executive functioning in individuals with
Parkinson’s disease. Overall, it was concluded that there does
not appear to be a language faculty independent of executive
functioning.
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